Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Henney, Herbert R."'
Autor:
Safirstein, Beth E., Ellenbogen, Aaron, Zhao, Ping, Henney, Herbert R., III, Kegler-Ebo, Deena M., Oh, Charles
Publikováno v:
In Clinical Therapeutics June 2020 42(6):1034-1046
Autor:
Henney, Herbert R., III, Sperling, Michael R., Rabinowicz, Adrian L., Bream, Gary, Carrazana, Enrique J.
Publikováno v:
In Epilepsy Research September 2014 108(7):1204-1211
Publikováno v:
In Clinical Therapeutics October 2009 31(10):2206-2214
Publikováno v:
In Clinical Therapeutics October 2009 31(10):2215-2223
Publikováno v:
In Clinical Therapeutics 2009 31(2):328-335
Publikováno v:
In Clinical Therapeutics 2008 30(12):2263-2271
Autor:
Henney, Herbert R., III, Shah, Jaymin
Publikováno v:
In Clinical Therapeutics 2007 29(4):661-669
Publikováno v:
In Clinical Therapeutics 2006 28(9):1308-1317
Publikováno v:
Annals of the New York Academy of Sciences. Nov2014, Vol. 1329 Issue 1, p33-44. 12p. 2 Diagrams, 1 Chart, 1 Graph.
Autor:
Yapundich, Robert, Applebee, Angela, Bethoux, Francois, Goldman, Myla D., Hutton, George J., Mass, Michele, Pardo, Gabriel, Klingler, Michael, Henney, Herbert R., Blight, Andrew R., Carrazana, Enrique J.
Dalfampridine extended-release (ER) tablets, 10 mg twice daily, have been shown to improve walking in people with multiple sclerosis. We evaluated the safety and efficacy of dalfampridine-ER 5 mg compared with 10 mg.Patients were randomized to double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ebea90cdbd95171161fd841941ab16e9
https://europepmc.org/articles/PMC4455866/
https://europepmc.org/articles/PMC4455866/
